Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
October 15, 2003
Büschke-Lowenstein tumour in pregnancy
G Garozzo, G Nuciforo, C M Rocchi, et al.
Cancer Research
|
February 19, 2008
The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium
Silvia Zecchini, Marco Bianchi, Nicoletta Colombo, et al.
Oncology Letters
|
June 29, 2012
Morphological and biomolecular characteristics of subcentimetric invasive breast carcinomas in Sicily: A multicentre retrospective study in relation to trastuzumab treatment
A Ieni, G Giuffrè, S Lanzafame, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2015
Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status
P G Nuciforo, C Aura, E Holmes, et al.
Oncotarget
|
October 10, 2015
MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients
Leticia De Mattos-Arruda, Giulia Bottai, Paolo G Nuciforo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 15, 2021
Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer
Zhen Shi, Julia Wulfkuhle, Malgorzata Nowicka, et al.
Molecular Cancer Therapeutics
|
September 5, 2021
A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway
Melanie Wurm, Otmar Schaaf, Katharina Reutner, et al.
Oncotarget
|
July 28, 2016
Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer
Marta Hergueta-Redondo, David Sarrio, Ángela Molina-Crespo, et al.
NPJ Genomic Medicine
|
May 29, 2024
Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients
Tom Venken, Ian S Miller, Ingrid Arijs, et al.
The EMBO Journal
|
August 22, 2025
Fusobacterium nucleatum interacts with cancer-associated fibroblasts to promote colorectal cancer
Jessica Karta, Marianne Meyers, Fabien Rodriguez, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
October 15, 2003
Büschke-Lowenstein tumour in pregnancy
G Garozzo, G Nuciforo, C M Rocchi, et al.
Cancer Research
|
February 19, 2008
The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium
Silvia Zecchini, Marco Bianchi, Nicoletta Colombo, et al.
Oncology Letters
|
June 29, 2012
Morphological and biomolecular characteristics of subcentimetric invasive breast carcinomas in Sicily: A multicentre retrospective study in relation to trastuzumab treatment
A Ieni, G Giuffrè, S Lanzafame, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2015
Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status
P G Nuciforo, C Aura, E Holmes, et al.
Oncotarget
|
October 10, 2015
MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients
Leticia De Mattos-Arruda, Giulia Bottai, Paolo G Nuciforo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 15, 2021
Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer
Zhen Shi, Julia Wulfkuhle, Malgorzata Nowicka, et al.
Molecular Cancer Therapeutics
|
September 5, 2021
A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway
Melanie Wurm, Otmar Schaaf, Katharina Reutner, et al.
Oncotarget
|
July 28, 2016
Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer
Marta Hergueta-Redondo, David Sarrio, Ángela Molina-Crespo, et al.
NPJ Genomic Medicine
|
May 29, 2024
Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients
Tom Venken, Ian S Miller, Ingrid Arijs, et al.
The EMBO Journal
|
August 22, 2025
Fusobacterium nucleatum interacts with cancer-associated fibroblasts to promote colorectal cancer
Jessica Karta, Marianne Meyers, Fabien Rodriguez, et al.
Page
of 4